GlaxoSmithKline [GLAXO] vs Glenmark [GLENMARK] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: GlaxoSmithKline wins in 9 metrics, Glenmark wins in 4 metrics, with 0 ties. GlaxoSmithKline appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGlaxoSmithKlineGlenmarkBetter
P/E Ratio (TTM)58.1559.75GlaxoSmithKline
Price-to-Book Ratio27.687.28Glenmark
Debt-to-Equity Ratio0.5127.94GlaxoSmithKline
PEG Ratio55.0652.15Glenmark
EV/EBITDA47.6320.99Glenmark
Profit Margin24.74%7.79%GlaxoSmithKline
Operating Margin33.07%13.69%GlaxoSmithKline
EBITDA Margin33.07%13.69%GlaxoSmithKline
Return on Equity49.75%12.54%GlaxoSmithKline
Return on Assets18.17%8.14%GlaxoSmithKline
Free Cash Flow$12.65B$-15.77BGlaxoSmithKline
Dividend Yield1.65%0.15%GlaxoSmithKline
1-Year Return26.76%57.88%Glenmark
Overview
Performance
Valuation
Financials
Short Interest
Dividends

GlaxoSmithKline vs Glenmark Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

GlaxoSmithKline vs Glenmark Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...